Test Directory
| Test Code | ||||||||||||||||||||||||||||||
| 2389 | ||||||||||||||||||||||||||||||
| Test Name | ||||||||||||||||||||||||||||||
| Simpson-Golabi-Behmel Syndrome, PIGA Related | ||||||||||||||||||||||||||||||
| CPT Codes | ||||||||||||||||||||||||||||||
| 81479 | ||||||||||||||||||||||||||||||
| Expected Turnaround Time | ||||||||||||||||||||||||||||||
| Typically 2 to 4 weeks from receipt of a sample in the laboratory. All cases involving ongoing pregnancies will be expedited. | ||||||||||||||||||||||||||||||
| Clinical Utility | ||||||||||||||||||||||||||||||
| Genetic analysis to provide a molecular diagnosis of this disorder. Recommended for individuals with a personal and/or family history of this disorder to ensure appropriate treatment and establish recurrence risk for family members. | ||||||||||||||||||||||||||||||
| Specimen and Container Info | ||||||||||||||||||||||||||||||
|
Non-Prenatal Specimens
Prenatal Specimens Either specimen type below is acceptable.
NOTE: For specimens from outside of North America, the preferred specimen type is Genomic DNA. HNL Genomics does not recommend shipping whole blood or cultured cells from any location other than the United States, Canada, or Mexico. |
||||||||||||||||||||||||||||||
| Transport Instructions | ||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
| Stability Requirements | ||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
| Causes for Rejection | ||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
| Methodology | ||||||||||||||||||||||||||||||
| Next Generation Sequencing and Copy Number Variation Analysis | ||||||||||||||||||||||||||||||
| Performing Location | ||||||||||||||||||||||||||||||
| Genomics - Snowdrift | ||||||||||||||||||||||||||||||
| Alternate Names | ||||||||||||||||||||||||||||||
| SOTOS1; SOTOS2; WVS; SGBS1 | ||||||||||||||||||||||||||||||
| Description | ||||||||||||||||||||||||||||||
|
Sotos syndrome 1 (SOTOS1; MIM 117550), Sotos syndrome 2 (SOTOS2; MIM 614753), Weaver syndrome (WVS; MIM 277590), and Simpson-Golabi-Behmel syndrome, type 1 (SGBS1; MIM 312870) are overgrowth syndromes characterized by pre- and postnatal overgrowth, accelerated osseous maturation, characteristic craniofacial appearance, and developmental delay. Sotos and Weaver syndromes are autosomal dominant disorders, which show considerable phenotypic overlap; however, these disorders also have some distinct clinical features. Congenital heart anomalies, scoliosis, renal abnormalities and seizures are common in Sotos syndrome, while WVS is associated with campodactyly, umbilical hernia, hoarse cry in infancy, and soft, doughy skin. Over 90% of individuals with Sotos syndrome have a mutation affecting the NSD1 gene (SOTOS1), which encodes a histone methyltransferase involved in gene regulation. WVS is caused by mutations in the EZH2 gene, which also encodes a histone methyltransferase. A few individuals with a Sotos-like syndrome have been reported to have mutations in NFIX (SOTOS2), which encodes a transcription factor involved in gene regulation. NFIX mutations can also cause Marshall-Smith syndrome (MRSHSS; MIM 602535), but this syndrome is not an overgrowth disorder. MRSHSS is an autosomal dominant disorder characterized by short stature, accelerated skeletal maturation, developmental delay, failure to thrive, respiratory difficulties, prominent forehead, proptosis, micrognathia, and kyphoscoliosis. Simpson-Golabi-Behmel syndrome is an X-linked recessive overgrowth disorder. SBGS1 can be distinguished from other overgrowth disorders by its unique set of features, including coarse facies, macrostomia, macroglossia, cleft palate, postaxial polydactyly, rib abnormalities, umbilical hernia, and congenital heart defects. SBGS1 is caused by mutations in the GPC3 gene, which encodes glypican 3, a heparin sulfate proteoglycan involved in several cell signaling pathways. Simpson-Golabi-Behmel syndrome, type 2 (SGBS2; MIM 300209) clinically overlaps with SGBS1. SGBS2 is more severe and often lethal in infancy. It is caused by mutations in the OFD1 gene. Mutations in this gene can also cause Orofaciodigital syndrome I (OFD1; MIM 311200) and Joubert syndrome 10 (JBTS10; MIM 300804). Mutations in the PIGA gene have also been reported in some patients with a SGBS2 phenotype (Simpson-Golabi-Behmel syndrome, PIGA related). |
||||||||||||||||||||||||||||||
| Testing Schedule | ||||||||||||||||||||||||||||||
| Monday-Friday | ||||||||||||||||||||||||||||||
| Genes | ||||||||||||||||||||||||||||||
| PIGA | ||||||||||||||||||||||||||||||
| Disease Group | ||||||||||||||||||||||||||||||
| Craniosynostosis and Craniofacial Disorders, Dysmorphology, Neuromuscular, Skeletal Disorders | ||||||||||||||||||||||||||||||
The American Medical Association (AMA) Current Procedural Terminology (CPT) codes published by HNL Lab Medicine are guidelines and are intended for informational purposes only. CPT coding is the exclusive responsibility of the billing entity. View the Terms.
© 2026 HNL Lab Medicine. All rights reserved.